| Systematic (IUPAC) name | |
|---|---|
| (8S,9S,10R,11S,13S,14S,16R,17S)-11-Hydroxy-10,13,16,17-tetramethyl-17-propanoyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one | |
| Clinical data | |
| AHFS/Drugs.com | monograph |
| MedlinePlus | a606003 |
| Pregnancy cat. | C (US) |
| Legal status | ? |
| Routes | occular |
| Identifiers | |
| CAS number | 49697-38-3 |
| ATC code | H02AB12 S01BA13 |
| PubChem | CID 16051942 |
| DrugBank | DB00896 |
| ChemSpider | 10482044 |
| UNII | O7M2E4264D |
| KEGG | D05729 |
| ChEMBL | CHEMBL1200617 |
| Chemical data | |
| Formula | C24H34O3 |
| Mol. mass | 370.525 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Rimexolone is a glucocorticoid steroid used to treat inflammation in the eye.[1] It is marketed as a 1% eye drop suspension under the trade name Vexol by Alcon Laboratories.
|
||||||||||||||||||||||||||||||||
| This hormonal preparation article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)